Pregnancy after embolization therapy for uterine arteriovenous malformation.
OBJECTIVE
To describe childbearing prognosis following embolization therapy for uterine arteriovenous malformation (AVM).


METHODS
Case report and review.


METHODS
University hospital.


METHODS
Thirteen patients, including our case, who underwent pregnancy after embolization therapy for arteriovenous malformation.


METHODS
Two successive embolization procedures.


METHODS
Childbearing prognosis following embolization therapy for uterine AVM.


RESULTS
Bilateral embolization was performed in seven patients. In four cases, including ours, two successive embolization procedures were required to treat the uterine AVM. The longest delay between embolization and pregnancy was 5 years and the shortest was six weeks. Two patients presented with postpartum hemorrhage which was treated medically. One neonate required resuscitation after delivery in the context of Listeria infection.


CONCLUSIONS
Conservative management of uterine AVMs using embolization therapy is being increasingly developed. New embolization agents and hyperselective technical procedures aim at reducing morbidity related to such treatments and preserving reproductive capacity in women of childbearing age.
Delotte
Jérôme
J
Service de Gynécologie-Obstétrique, Reproduction et Médecine Faetale, Centre Hospitalier Universitaire de l'Archet II, Nice, France. jdelotte@hotmail.com
Chevallier
Patrick
P
Benoit
Bernard
B
Castillon
Jean-Michel
JM
Bongain
André
A
D000328:Adult; D001165:Arteriovenous Malformations / Q000628:therapy*; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D011247:Pregnancy; D011256:Pregnancy Outcome; D011379:Prognosis; D014599:Uterus / Q000098:blood supply*